Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 88 | 88 | 88 | 88 | 88 |
| Operating Expenses | 563 | 439 | 560 | 634 | 890 |
| Operating Income | -475 | -350 | -471 | -546 | -802 |
| Interest Expense | 0 | 2 | N/A | N/A | N/A |
| Other Income | -615 | -435 | -362 | -290 | -247 |
| Pre-tax Income | -1,090 | -787 | -833 | -836 | -1,049 |
| Net Income Continuous | -1,111 | -787 | -833 | -836 | -1,049 |
| Net Income | $-1,111 | $-787 | $-833 | $-836 | $-1,049 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EBITDA(a) | $-1,089 | $-786 | $-2,240 | $-546 | $-801 |